Cross-talk between SIRT1 and p66Shc in vascular diseases

Trends in Cardiovascular Medicine

Volumn 23, Issue 7, 2013, Pages 237-241

  Chen, Hou Zao ^a   Wan, Yan Zhen ^a   Liu, De Pei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; ADAPTOR PROTEIN; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; GLUCOSE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; OXIDOREDUCTASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; PROTEIN P66SHC; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG;

AGING; ANTIOXIDANT ACTIVITY; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL AGING; CELLULAR STRESS RESPONSE; DOWN REGULATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; LIFESPAN; LONGEVITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; CELL AGING; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; LONGEVITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; SIRTUIN 1; VASCULAR DISEASES;

EID: 84883829745     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.01.001     Document Type: Review

References (54)

1. Alcendor R.R., Gao S., Zhai P., et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research 2007, 100:1512-1521.
2. Ballinger S.W., Patterson C., Knight-Lozano C.A., et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
3. Brunet A., Sweeney L.B., Sturgill J.F., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
4. Camici G.G., Cosentino F., Tanner F.C., Luscher T.F. The role of p66Shc deletion in age-associated arterial dysfunction and disease states. Journal of Applied Physiology 2008, 105:1628-1631.
5. Camici G.G., Schiavoni M., Francia P., et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:5217-5222.
6. Chen H., Wan Y., Zhou S., et al. Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence. Science China Life Sciences 2012, 55:467-473.
7. Colman R.J., Anderson R.M., Johnson S.C., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
8. El Assar M., Angulo J., Vallejo S., Peiro C., Sanchez-Ferrer C.F., Rodriguez-Manas L. Mechanisms involved in the aging-induced vascular dysfunction. Frontiers in Physiology 2012, 3:132.
9. Feige J.N., Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Current Opinion in Cell Biology 2008, 20:303-309.
10. Francia P., delli Gatti C., Bachschmid M., et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004, 110:2889-2895.
11. Giorgio M., Migliaccio E., Orsini F., et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
12. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
13. Graiani G., Lagrasta C., Migliaccio E., et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005, 46:433-440.
14. Guarente L., Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. The New England Journal of Medicine 2011, 364:2235-2244.
15. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annual Review of Pathology 2010, 5:253-295.
16. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nature Reviews Molecular Cell Biology 2012, 13:225-238.
17. Hsu C.P., Zhai P., Yamamoto T., et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010, 122:2170-2182.
18. Kanfi Y., Naiman S., Amir G., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
19. 2-induced oxidative stress and senescence via SirT1 activation. Journal of Atherosclerosis and Thrombosis 2010, 17:970-979.
20. Khanday F.A., Yamamori T., Mattagajasingh I., et al. Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Molecular Biology of the Cell 2006, 17:122-129.
21. Kim C.S., Jung S.B., Naqvi A., et al. p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc. Circulation Research 2008, 103:1441-1450.
22. Kim C.S., Kim Y.R., Naqvi A., et al. Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. Cardiovascular Research 2011, 92:466-475.
23. Li L., Zhang H.N., Chen H.Z., et al. SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circulation Research 2011, 108:1180-1189.
24. Li X., Kazgan N. Mammalian sirtuins and energy metabolism. International Journal of Biological Sciences 2011, 7:575-587.
25. Luo J., Nikolaev A.Y., Imai S., et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107:137-148.
26. Mattagajasingh I., Kim C.S., Naqvi A., et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14855-14860.
27. Menini S., Amadio L., Oddi G., et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 2006, 55:1642-1650.
28. Migliaccio E., Giorgio M., Mele S., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
29. Migliaccio E., Mele S., Salcini A.E., et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. The EMBO Journal 1997, 16:706-716.
30. Napoli C., Martin-Padura I., de Nigris F., et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2112-2116.
31. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
32. Orimo M., Minamino T., Miyauchi H., et al. Protective role of SIRT1 in diabetic vascular dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:889-894.
33. Orsini F., Migliaccio E., Moroni M., et al. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. Journal of Biological Chemistry 2004, 279:25689-25695.
34. Ota H., Akishita M., Eto M., Iijima K., Kaneki M., Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. Journal of Molecular and Cellular Cardiology 2007, 43:571-579.
35. Ota H., Eto M., Kano M.R., et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:2205-2211.
36. Ota H., Eto M., Kano M.R., et al. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:1634-1639.
37. Paneni F., Mocharla P., Akhmedov A., et al. Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circulation Research 2012, 111:278-289.
38. Pinton P., Rimessi A., Marchi S., et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315:659-663.
39. Potente M., Ghaeni L., Baldessari D., et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes and Development 2007, 21:2644-2658.
40. Purkayastha S., Zhang G., Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nature Medicine 2011, 17:883-887.
41. Purkayastha S., Zhang H., Zhang G., Ahmed Z., Wang Y., Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2939-2944.
42. Ranieri S.C., Fusco S., Panieri E., et al. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13420-13425.
43. Rocha M., Apostolova N., Hernandez-Mijares A., Herance R., Victor V.M. Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. Current Medicinal Chemistry 2010, 17:3827-3841.
44. Schnabel R., Blankenberg S. Oxidative stress in cardiovascular disease: successful translation from bench to bedside?. Circulation 2007, 116:1338-1340.
45. Schulz E., Gori T., Munzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertension Research 2011, 34:665-673.
46. Spescha R.D., Shi Y., Wegener S., et al. Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury. European Heart Journal 2012, 2012 Sep 24, [Epub ahead of print].
47. Stein S., Lohmann C., Schafer N., et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European Heart Journal 2010, 31:2301-2309.
48. Trinei M, Giorgio M, Cicalese A., Barozzi S., Ventura A., Migliaccio E., Milia E., et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002, 21:3872-3878.
49. Ungvari Z., Labinskyy N., Mukhopadhyay P., et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology 2009, 297:H1876-1881.
50. Ventura A., Luzi L., Pacini S., Baldari C.T., Pelicci P.G. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. Journal of Biological Chemistry 2002, 277:22370-22376.
51. Wang F., Chen H.Z., Lv X., Liu D.P. SIRT1 as a novel potential treatment target for vascular aging and age-related vascular diseases. Current Molecular Medicine 2012, 2012 Aug 31, [Epub ahead of print].
52. Zhang Q.J., Wang Z., Chen H.Z., et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovascular Research 2008, 80:191-199.
53. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135:61-73.
54. Zhou S., Chen H.Z., Wan Y.Z., et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circulation Research 2011, 109:639-648.